On September 10, New Oxygen Technology (NASDAQ: SY), a leading domestic Internet medical and aesthetic medical service platform, released its unaudited financial results for the second quarter ended June 30, 2021.
The financial report shows that in the second quarter of 2021, the total revenue of New Oxygen Technology is 451.8 million yuan (70 million US dollars), a record high, a year-on-year increase of 37.7%. In terms of other key indicators, non-US GAAP net profit attributable to listed companies was 73.7 million yuan ($8.9 million), a year-on-year increase of 145.2%. The average monthly active users of the mobile terminal are 10 million, a year-on-year increase of 47.5%. The number of paying medical institutions was 4,899, a year-on-year increase of 31.2%. The number of paying users was 245,000, a year-on-year increase of 43.6%.
Behind the dazzling financial report data is the trust from both ends of the supply and demand of medical aesthetics, and this trust is mainly due to the long-term strategic layout of New Oxygen.
On the one hand, an active and real community, a high-quality and popular new media matrix, and online tools to assist decision-making have become the basic disk for Xinyang to win the coverage of core users of medical aesthetics. On the other hand, while consolidating the traditional advantages of surgical medical aesthetics services, the competition barriers of non-surgical services have been continuously strengthened. Including the promotion of the standardization of non-surgical medical aesthetic services in the form of "Mecicard" and other business forms, New Oxygen has gathered more than 100 professional doctors to create a "Mecicard light medical aesthetics ranking list", fair and open through a third party , Fair review, to further force the medical aesthetics industry chain to standardize products and services, realize "good money drives out bad money", and purify the market environment.
In addition, deepening into the industry chain, strengthening cooperation with upstream manufacturers, and strengthening the control over the authenticity of products and equipment from the source are also part of the strategic layout of New Oxygen.
Take the Xinyang free experience project as an example. Through expansion and linkage with upstream manufacturers and institutions, more than 3000 brands and institutions provide the latest medical aesthetic experience every day, ensuring the quality of experience projects and products. According to data from the New Oxygen Data Yan Research Institute, as of August this year, more than 2.1 million people have participated in the new oxygen free experience activities, and more than 110,000 real diaries have been generated.
In the second quarter of this year, Xinyang acquired the upstream optoelectronic equipment manufacturer Wuhan Qizhi Laser, further expanding the new idea of cooperation between the vertical medical beauty platform and upstream manufacturers. A few days ago, high-end optoelectronic anti-aging brands such as Qizhi Laser, Fotona Eurostar, Keyiren, Sinoshow, Sinoron (Zhenmei carefully selected), Feidun Laser and other high-end optoelectronic anti-aging brands collectively settled in Xinyang to open brand flagship stores, bringing more than 1,000 The authorized medical beauty institution of the country provides consumers with authentic and guaranteed anti-aging medical beauty services.
Gong Wei, deputy secretary-general of Chengdu Medical Beauty Industry Association, believes that direct access to star products with genuine guarantees from the medical aesthetics platform is equivalent to providing natural protection for consumers' medical aesthetics services. The establishment of the flagship stores of the six major brands can not only expand the service network of New Oxygen on the institutional side, but also penetrate into the user performance link, ensure that users enjoy the authentic consumption experience, and make the competition of New Oxygen in the field of non-surgical medical aesthetics more diversified. , The formation of long-term barriers to competition.
New Oxygen also continues to promote industry self-discipline and avoid pits in popular science, medical and beauty consumption, and promote the healthy development of the industry in compliance. As early as May 2020, Xinyang joined with the China Plastic Surgery Association to take the lead in launching a self-discipline action for the Chinese medical aesthetics industry. As of July 18, 2021, New Oxygen has intercepted 1503428 cases of suspected illegal and illegal medical beauty products, 16039 times of institutions, 38,771 illegal or out-of-scope practicing doctors, and 2,163,426 times of false orders and evaluations, and a total of interception and disposal of illegal and illegal medical beauty information Nearly 4 million times.
In March of this year, New Oxygen released the first guide to avoiding pitfalls in medical aesthetics consumption in China's medical aesthetics industry to promote the systematization of popularization of medical aesthetics. In June and July, New Oxygen successively launched articles on medical aesthetics and consumption to avoid pits, eyes and noses, and controversial items to provide consumers with professional advice and early warning. Not long ago, Xinyang and Xinhua Finance released the "2021 China Medical Beauty Anti-aging Consumption Trend Report", summarizing common pitfalls in the field of medical beauty anti-aging, and inviting professional doctors to give advice on “avoiding pits”.
Continuous investment to help users strictly screen medicines, medical devices and institutions, make users feel more comfortable, and return medical beauty to the essence of medical treatment. This is the original intention of New Oxygen since its establishment, and it is also the key to New Oxygen to continue to win the trust of users and the industry. Just as Jin Xing, Chairman and CEO of New Oxygen Technology, said, "Looking forward to the future, in the face of the rapid growth of China's medical aesthetics industry, we will continue to strive to become the most trusted medical aesthetics medical service platform."